Specialist diagnostics partner in the Benelux
+31 (0)85 0045479 Mon–Fri 08:30–17:00 · -
Pharmacogenetics
Viennalab Distributed by Goffin Diagnostics

CVD StripAssay T

The Viennalab CVD StripAssay T identifies nine variants in six genes associated with an increased risk of thrombosis and cardiovascular disease: Factor V G1691A (Leiden) and H1299R (R2), prothrombin G20210A, MTHFR C677T and A1298C, Factor XIII V34L, PAI-1 4G/5G, and EPCR A4600G and G4678C. The kit works from fresh or frozen EDTA or citrate blood and contains the lysis solution and resin for releasing DNA. Taq DNA Polymerase is not supplied and has to be ordered separately.

Strip Assay CE-IVDR Viennalab 1 Package (20 Tests)
Technique
Strip Assay
Brand
Viennalab
Packaging
1 Package (20 Tests)
Download documentation
Automate on DYNABLOT Heat See the instrument that automates this assay

Quote-based, no public pricing. Add to your quote and our specialists put together a proposal with the right documentation, typically within 24 hours.

Product details

This kit in detail

  • Nine variants in six genes: F5, prothrombin, MTHFR, F13, PAI-1 and EPCR
  • Factor V Leiden and R2, prothrombin G20210A, MTHFR C677T and A1298C
  • Reverse hybridisation on a test strip, read by eye
  • Lysis solution and GENxTRACT resin included for whole blood
  • Taq DNA Polymerase not supplied, ordered separately
  • 20 tests per kit, REF 4-360

The Viennalab CVD StripAssay T determines nine variants that together make up a thrombophilia and cardiovascular risk profile, in a single reverse hybridisation run.

Variants covered

Factor V G1691A (Leiden) and Factor V H1299R (R2); prothrombin G20210A; MTHFR C677T and A1298C; Factor XIII V34L; PAI-1 4G/5G; and EPCR A4600G and G4678C. The IFU prints only this legacy nomenclature, without protein designations or HGVS notation.

Clinical background

Factor V Leiden and prothrombin G20210A are the two most frequent hereditary risk factors for venous thromboembolism. The MTHFR variants affect homocysteine metabolism, PAI-1 4G/5G affects fibrinolytic capacity, Factor XIII V34L is described as protective, and the EPCR variants concern the endothelial protein C receptor. A profile of this kind is determined in the work-up of unexplained thrombosis or a positive family history, and the interpretation depends on the combination rather than on a single variant.

Method and sample

The assay amplifies with biotinylated primers and hybridises the products to allele-specific probes on a test strip, detected with streptavidin-alkaline phosphatase and a colour substrate and read by eye against the supplied Collector sheet. Fresh or frozen blood with EDTA or citrate as anticoagulant is used; blood with heparin is not suitable. The kit contains the lysis solution and GENxTRACT resin for releasing DNA from whole blood. Taq DNA Polymerase is not supplied and is ordered separately as ViennaLab TAQ-500 or TAQ-2500. For DNA prepared outside the kit protocol, a concentration of 2 to 10 ng/µl is recommended, which is 10 to 50 ng per reaction.

  • Lysis Solution (50 ml)
  • GENXTRACTTM Resin (5 ml)
  • Amplification Mix (yellow cap, 500 µl)
  • Taq Dilution Buffer (transparent cap, 500 µl)
  • DNAT (blue cap, 1.5 ml)
  • Typing Trays (3)
  • Teststrips (20)
  • Hybridization Buffer (white cap, 25 ml)
  • Wash Solution A (white cap, 80 ml)
  • Conjugate Solution (25 ml)
  • Wash Solution B (80 ml)
  • Color Developer (25 ml)
  • CollectorTM Sheet (1)
Documentation

Datasheets and regulatory documentation

Everything your quality team needs for evaluation and procurement.

Let’s talk diagnostics

Add this kit to your quote

Tell us the platforms and throughput you’re planning for and our specialists will put together a clear proposal with the right documentation, no public pricing, just a considered answer.